Skip to main content
BLRX logo

BLRX

BioLineRx Ltd.
$2.98 +0.07 (+2.41%) At close · Jul 16
Market Cap
$13.41M
Shares
4,499,411

Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score
66/100
Short interest 3.0% of shares — P59 Days to cover 7.4 — P91 Price vs VWAP +3.0% — P66 Short-volume trend +2.2% — P60 Short interest change -5.9% — P31 Worst FTD 0.11% of shares — P77

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-06-30 136,651 145,190 -8,539 7.42
2026-06-15 145,190 166,615 -21,425 7.38
2026-05-29 166,615 139,481 +27,134 1.00
2026-05-15 139,481 157,501 -18,020 7.11
2026-04-30 157,501 154,748 +2,753 5.09
2026-04-15 154,748 163,818 -9,070 10.34
2026-03-31 163,818 167,577 -3,759 8.64
2026-03-13 167,577 169,422 -1,845 19.08
2026-02-27 169,422 167,251 +2,171 16.24
2026-02-13 167,251 173,117 -5,866 12.60
2026-01-30 173,117 176,509 -3,392 9.43
2026-01-15 176,509 187,804 -11,295 11.08
2025-12-31 187,804 173,116 +14,688 6.98
2025-12-15 173,116 180,527 -7,411 6.84
2025-11-28 180,527 180,688 -161 5.83
2025-11-14 180,688 188,036 -7,348 9.27
2025-10-31 188,036 189,496 -1,460 7.31
2025-10-15 189,496 190,049 -553 6.10
2025-09-30 190,049 170,691 +19,358 2.96
2025-09-15 170,691 181,214 -10,523 4.67
2025-08-29 181,214 203,233 -22,019 5.59
2025-08-15 203,233 166,481 +36,752 4.66
2025-07-31 166,481 189,833 -23,352 5.28
Showing 1–23 of 23 settlements
Key facts CIK 1498403 CUSIP 09071M304 Visit website Investor relations